Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study

S. W. Kim, S. J. Mori, R. Tanosaki, T. Fukuda, M. Kami, H. Sakamaki, T. Yamashita, Y. Kodera, S. Terakura, S. Taniguchi, S. Miyakoshi, N. Usui, S. Yano, Y. Kawano, Y. Nagatoshi, M. Harada, Y. Morishima, S. Okamoto, A. M. Saito, Y. OhashiR. Ueda, Y. Takaue

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Fingerprint Dive into the research topics of 'Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study'. Together they form a unique fingerprint.

Medicine & Life Sciences